ReviewFrontiers in pharmacology2020
Traditional Herbal Medicine in Mesoamerica: Toward Its Evidence Base for Improving Universal Health Coverage.
Review in Frontiers in pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 71 citations in OpenAlex.
- Digital exclusion, functional limitations transitions, and life expectancy: a multinational longitudinal study.SSM - population health · 2026Article
- Beyond Tradition: An Integrated Toxicological, Ecological, and Public Health Perspective on Aristolochic Acids.Journal of applied toxicology : JAT · 2026Review
- Evidence and Tradition in Dialogue: Biological Sex Variability in Phytomedicine Research as a Foundation for Safety, Efficacy, and Robust Evidence Standards.Medicines (Basel, Switzerland) · 2026Review
- Social Support, Traditional Care Practices, and Mental Health in Rural Ecuadorian Youth.medRxiv : the preprint server for health sciences · 2026Article
- Moving beyond the empty cell: The threat of decontextualized healthcare data.PLOS digital health · 2026Review
- Herbal or conventional medicine? A cross-sectional study of Jordanian university students' preferences for cold and flu treatment.PloS one · 2026Observational
- Nephroprotective activity of Eysenhardtia polystachya through antioxidant, HNaunyn-Schmiedeberg's archives of pharmacology · 2025Article
- Article
- Functional, Antioxidant, and Antimicrobial Profile of Medicinal Leaves from the Amazon.Antioxidants (Basel, Switzerland) · 2025Article
- From phytochemicals to recipes: health indications and culinary uses of herbs and spices.NPJ science of food · 2025Article
- Towards culturally inclusive healthcare in Peru: Mapping epistemic concepts in contemporary Indigenous Amazonian medicine-Traditional healers' perspectives.PLOS global public health · 2025Article
- Editorial: Traditional clinical symptoms and signs: how can they be used to investigate medications in the context of pharmacology?Frontiers in pharmacology · 2025Article
- Coexisting traditional and biomedical healthcare systems: a mixed-methods analysis of community health workers and traditional birth attendants' contributions to perinatal health behaviors in rural India.Frontiers in health services · 2025Article
- Article
- Article
- Technology Readiness Level Roadmap for Developing Innovative Herbal Medicinal Products.Pharmaceuticals (Basel, Switzerland) · 2024Article
- Are we romanticizing traditional knowledge? A plea for more experimental studies in ethnobiology.Journal of ethnobiology and ethnomedicine · 2024Article
- Use of complementary and alternative medicine by cancer patients in Colombia.BMC complementary medicine and therapies · 2023Review
- A Perspective on Missing Aspects in Ongoing Purification Research towardsFoods (Basel, Switzerland) · 2023Review
- Mexican traditional medicines for women's reproductive health.Scientific reports · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 4 institutions in 5 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The quality of health care in Mesoamerica is influenced by its rich cultural diversity and characterized by social inequalities. Especially indigenous and rural communities confront diverse barriers to accessing formal health services, leading to often conflicting plurimedical systems. Fostering integrative medicine is a fundamental pillar for achieving universal health coverage (UHC) for marginalized populations. Recent developments toward health sovereignty in the region are concerned with assessing the role of traditional medicines, and particularly herbal medicines, to foster accessible and culturally pertinent healthcare provision models. In Mesoamerica, as in most regions of the world, a wealth of information on traditional and complementary medicine has been recorded. Yet these data are often scattered, making it difficult for policy makers to regulate and integrate traditionally used botanical products into primary health care. This critical review is based on a quantitative analysis of 28 survey papers focusing on the traditional use of botanical drugs in Mesoamerica used for the compilation of the "Mesoamerican Medicinal Plant Database" (MAMPDB), which includes a total of 12,537 use-records for 2188 plant taxa. Our approach presents a fundamental step toward UHC by presenting a pharmacological and toxicological review of the cross-culturally salient plant taxa and associated botanical drugs used in traditional medicine in Mesoamerica. Especially for native herbal drugs, data about safety and effectiveness are limited. Commonly used cross-culturally salient botanical drugs, which are considered safe but for which data on effectiveness is lacking constitute ideal candidates for treatment outcome studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.